These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4301558)

  • 1. The chromophore and partial structure of viomycin.
    Bycroft BW; Cameron D; Croft LR; Hassanali-Walji A; Johnson AW; Webb T
    Tetrahedron Lett; 1968 Dec; (56):5901-4. PubMed ID: 4301558
    [No Abstract]   [Full Text] [Related]  

  • 2. The structure of the guanido amino acid moiety of viomycin.
    Takita T; Maeda K
    J Antibiot (Tokyo); 1968 Aug; 21(8):512-6. PubMed ID: 4303539
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on viomycin IX. Amino acid derivatives on viomycin.
    Kitagawa T; Miura T; Takaishi C; Taniyama H
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1324-30. PubMed ID: 191204
    [No Abstract]   [Full Text] [Related]  

  • 4. Viomycin. II. The structure of the chromophore.
    Bycroft BW; Cameron D; Croft LR; Hassanali-Walji A; Johnson AW; Webb T
    J Chem Soc Perkin 1; 1972; 6():827-34. PubMed ID: 4338113
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical studies on tuberactinomycin. 3. The chemical structure of viomycin (tuberactinomycin B).
    Noda T; Take T; Nagata A; Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1972 Jul; 25(7):427-8. PubMed ID: 4350196
    [No Abstract]   [Full Text] [Related]  

  • 6. The total structure of viomycin by sequential analysis.
    Kitagawa T; Miura T; Fujiwara K; Taniyama H
    Chem Pharm Bull (Tokyo); 1972 Oct; 20(10):2215-25. PubMed ID: 4346588
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on viomycin. VII. Oxidative modifications of viomycin.
    Kitagawa T; Miura T; Sawada Y; Fujiwara K; Ito R
    Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1827-34. PubMed ID: 4371987
    [No Abstract]   [Full Text] [Related]  

  • 8. Vinomycin I. The amino acid sequence of viomycin.
    Kitagawa T; Sawada Y; Miura T; Ozasa T; Taniyama H
    Tetrahedron Lett; 1968 Jan; 1():109-13. PubMed ID: 4298709
    [No Abstract]   [Full Text] [Related]  

  • 9. The structure, stereochemistry and reactions of the guanidine moiety of viomycin.
    Bycoft BW; Croft LR; Johnson AW; Webb T
    J Antibiot (Tokyo); 1969 Mar; 22(3):133-4. PubMed ID: 4307101
    [No Abstract]   [Full Text] [Related]  

  • 10. Viomycin.
    Lechowski L
    Tetrahedron Lett; 1969 Feb; (6):479-82. PubMed ID: 4307473
    [No Abstract]   [Full Text] [Related]  

  • 11. Viomycin. Further degradative studies.
    Bycroft BW; Cameron D; Croft LR; Johnson AW; Webb T; Coggon P
    Tetrahedron Lett; 1968 May; (25):2925-30. PubMed ID: 4297159
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of a model relating to the chromophores of capreomycin and viomycin.
    Bycroft BW; Cameron D; Hassanali-Walji A; Johnson AW
    Tetrahedron Lett; 1969 Jun; (30):2539-41. PubMed ID: 4308326
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction between 30 S ribosomal components in a viomycin resistant mutant of Mycobacterium smegmatis.
    Mizuguchi Y; Suga K; Yamada T
    Microbiol Immunol; 1979; 23(7):595-604. PubMed ID: 228161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-amino-proline from viomycidine.
    Gallina C; Koch V; Romeo A
    Tetrahedron Lett; 1969 Jul; (35):3055-6. PubMed ID: 4308886
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosynthesis of viomycin. I. Origin of alpha, beta-diaminopropionic acid and serine.
    Carter JH; Du Bus RH; Dyer JR; Floyd JC; Rice KC; Shaw PD
    Biochemistry; 1974 Mar; 13(6):1221-7. PubMed ID: 4360782
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosynthesis of viomycin. II. Origin of beta-lysine and viomycidine.
    Carter JH; Du Bus RH; Dyer JR; Floyd JC; Rice KC; Shaw PD
    Biochemistry; 1974 Mar; 13(6):1227-33. PubMed ID: 4360783
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular and crystal structure of viomycidine.
    Koyama G; Nakamura H; Omoto S; Takita T; Maeda K
    J Antibiot (Tokyo); 1969 Jan; 22(1):34-5. PubMed ID: 4305865
    [No Abstract]   [Full Text] [Related]  

  • 18. 13C-nuclear magnetic magnetic resonance studies on viomycin and its related compounds.
    Kitagawa T; Miura T; Mori K; Taniyama H; Kawano K; Kyogoku Y
    Chem Pharm Bull (Tokyo); 1977 Feb; 25(2):280-4. PubMed ID: 192477
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationships between antimicrobial activities and chemical structures of reduced products of viomycin.
    Kitagawa T; Miura T; Tanaka S; Taniyama H
    J Antibiot (Tokyo); 1973 Sep; 26(9):528-31. PubMed ID: 4365319
    [No Abstract]   [Full Text] [Related]  

  • 20. THE OTOTOXICITY OF KANAMYCIN. A THEORETICAL AND EXPERIMENTAL STUDY.
    DEGREEF I
    Acta Otorhinolaryngol Belg; 1964; 18():415-27. PubMed ID: 14205308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.